# PREVALENCE OF Anti-CCP POSITIVITY AND SUBCLINICAL SIGNS OF INFLAMMATION IN PATIENTS WITH NEW ONSET OF NON-SPECIFIC MUSCULOSKELETAL SYMPTOMS

> **NCT03267147** · — · COMPLETED · sponsor: **Fraunhofer Institute for Translational Medicine and Pharmacology ITMP** · enrollment: 986 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **OTHER:** no intervention is given

## Key facts

- **NCT ID:** NCT03267147
- **Lead sponsor:** Fraunhofer Institute for Translational Medicine and Pharmacology ITMP
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-27
- **Primary completion:** 2021-12-16
- **Final completion:** 2022-02-15
- **Target enrollment:** 986 (ACTUAL)
- **Last updated:** 2022-03-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03267147

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03267147, "PREVALENCE OF Anti-CCP POSITIVITY AND SUBCLINICAL SIGNS OF INFLAMMATION IN PATIENTS WITH NEW ONSET OF NON-SPECIFIC MUSCULOSKELETAL SYMPTOMS". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03267147. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*